Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes

Nephrology Dialysis Transplantation

Volumn 25, Issue 7, 2010, Pages 2231-2237

  Jaziri, Riphed ^a,b   Aubert, Roberte ^a   Roussel, Ronan ^a,b,c   Emery, Nathalie ^a,b   Maimaitiming, Suliya ^a,b   Bellili, Naïma ^a,b   Miot, Aurélie ^a,b   Saulnier, Pierre Jean ^d   Travert, Florence ^c   Hadjadj, Samy ^d   Marre, Michel ^a,b,c   Fumeron, Frédéric ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BICHAT HOSPITAL   (France)

^d POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

adiponectin; genetic polymorphisms; nephropathy; prospective study; type 2 diabetes

Indexed keywords

ADIPONECTIN; ALBUMIN; RAMIPRIL; ISOPROTEIN;

AGED; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENE; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GROUPS BY AGE; HAPLOTYPE; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA; SINGLE NUCLEOTIDE POLYMORPHISM; URINARY EXCRETION; BLOOD; CASE CONTROL STUDY; COMPLICATION; DIABETIC NEPHROPATHY; FOLLOW UP; FRANCE; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; MIDDLE AGED; RISK FACTOR;

ADIPONECTIN; AGED; ALLELES; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; FRANCE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; RISK FACTORS;

EID: 77954316830     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp771     Document Type: Article

References (28)

1. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 3106: 356-360
2. Fumeron F, Aubert R, Siddiq A et al. Epidemiologic Data on the Insulin Resistance Syndrome (DESIR) Study Group: adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 2004; 53: 1150-1157
3. Menzaghi C, Trischitta V, Doria A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 2007; 56: 1198-1209
4. Shen YY, Charlesworth JA, Kelly JJ et al. Up-regulation of adiponec-tin, its isoforms and receptors in end-stage kidney disease. Nephrol Dial Transplant 2007; 22: 171-178
5. Kollerits B, Fliser D, Heid IM et al. Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int 2007; 71: 1279-1286 (Pubitemid 46884246)
6. Saraheimo M, Forsblom C, Fagerudd J et al. Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care 2005; 28: 1410-1414
7. Schalkwijk CG, Chaturvedi N, Schram MT et al. For the EURO-DIAB Prospective Complications Study Group. Adiponectin is inversely associated with renal function in type 1 diabetic patients. J Clin Endocrinol Metab 2006; 91: 129-135
8. Looker HC, Krakoff J, Funahashi T et al. Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 4010-4017
9. Stenvinkel P, Marchlewska A, Pecoits-Filho R et al. Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 2004; 65: 274-281
10. Hadjadj S, Aubert R, Fumeron F et al. Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects. Diabetologia 2005; 48: 1088-1092
11. Waki H, Yamauchi T, Kamon J et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003; 278: 40352-40363
12. Marre M, Lievre M, Chatellier G et al. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). BMJ 2004; 328: 495-500
13. Hadjadj S, Fumeron F, Roussel R et al. Prognostic value of the insertion/deletion polymorphism of angiotensin I-converting enzyme gene in type 2 diabetic subjects: results from the DIABHYCAR, DIA-B2NEPHROGENE &SURDIAGENE studies. Diabetes Care 2008; 31: 1847-1852
14. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005; 15: 97-98
15. Vionnet N, Tregouet D, Kazeem G et al. Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene. Diabetes 2006; 55: 3166-3174
16. Jorsal A, Tarnow L, Frystyk J et al. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int 2008; 74: 649-654
17. Prior SL, Javid J, Gill GV et al. The adiponectin rs17300539 G A variant and nephropathy risk. Kidney Int 2008; 74: 1361
18. Bouatia-Naji N, Meyre D, Lobbens S et al. ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes 2006; 55: 545-550
19. Heid IM, Wagner SA, Gohlke H et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 2006; 55: 375-384
20. Sharma K, Ramachandrarao S, Qiu G et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 2008; 118: 1645-1656
21. Chen H, Montagnani M, Funahashi T et al. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003; 278: 45021-45026
22. Ito S, Arima S, Ren YL et al. Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microper-fused rabbit afferent but not efferent arteriole. J Clin Invest 1993; 91: 2012-2019
23. Hattori Y, Hattori S, Akimoto K et al. Globular adiponectin activates nuclear factor-kappaB and activating protein-1 and enhances angio-tensin II-induced proliferation in cardiac fibroblasts. Diabetes 2007; 56: 804-808
24. Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta 2007; 380: 24-30
25. Tsao TS, Murrey HE, Hug C et al. Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem 2002; 277: 29359-29362
26. Neumeier M, Weigert J, Schaffler A et al. Different effects of adipo-nectin isoforms in human monocytic cells. J Leukoc Biol 2006; 79: 803-808
27. Tomizawa A, Hattori Y, Kasai K et al. Adiponectin induces NF-kappaB activation that leads to suppression of cytokine-induced NF-kappaB activation in vascular endothelial cells: globular adipo-nectin vs. high molecular weight adiponectin. Diab Vasc Dis Res 2008; 5: 123-127
28. Guo LL, Pan Y, Jin HM. Adiponectin is positively associated with insulin resistance in subjects with type 2 diabetic nephropathy and effects of angiotensin II type 1 receptor blocker losartan. Nephrol Dial Transplant 2009; 24: 1876-1883